Information card for entry 4510485
| Common name |
Blonanserinium succinate salt |
| Chemical name |
(2-(4-ethyl-l-piperazinyl)-4-(4-fluorophenyl)-5, 6, 7, 8, 9, 10-hexahydrocycloocta[ b]-pyridine)-1,4-Butanedioic acid |
| Formula |
C27 H36 F N3 O4 |
| Calculated formula |
C27 H36 F N3 O4 |
| SMILES |
O=C([O-])CCC(=O)O.Fc1ccc(c2c3CCCCCCc3nc(N3CC[NH+](CC3)CC)c2)cc1 |
| Title of publication |
High Solubility Crystalline Pharmaceutical Forms of Blonanserin |
| Authors of publication |
Maddileti, D.; Swapna, Battini; Nangia, Ashwini |
| Journal of publication |
Crystal Growth & Design |
| Year of publication |
2014 |
| Journal volume |
14 |
| Journal issue |
5 |
| Pages of publication |
2557 |
| a |
8.9999 ± 0.0009 Å |
| b |
13.0762 ± 0.0013 Å |
| c |
21.704 ± 0.002 Å |
| α |
90° |
| β |
90° |
| γ |
90° |
| Cell volume |
2554.2 ± 0.4 Å3 |
| Cell temperature |
100 ± 2 K |
| Ambient diffraction temperature |
100 ± 2 K |
| Number of distinct elements |
5 |
| Space group number |
19 |
| Hermann-Mauguin space group symbol |
P 21 21 21 |
| Hall space group symbol |
P 2ac 2ab |
| Residual factor for all reflections |
0.0367 |
| Residual factor for significantly intense reflections |
0.0339 |
| Weighted residual factors for significantly intense reflections |
0.0762 |
| Weighted residual factors for all reflections included in the refinement |
0.0774 |
| Goodness-of-fit parameter for all reflections included in the refinement |
1.032 |
| Diffraction radiation wavelength |
0.71073 Å |
| Diffraction radiation type |
MoKα |
| Has coordinates |
Yes |
| Has disorder |
No |
| Has Fobs |
No |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/4510485.html